286 related articles for article (PubMed ID: 28463521)
21. Are we ready for dual-time point FDG PET imaging?
Lee ST; Scott AM
J Med Imaging Radiat Oncol; 2011 Aug; 55(4):351-2. PubMed ID: 21843168
[No Abstract] [Full Text] [Related]
22. PET Molecular Imaging-Directed Biopsy: A Review.
Fei B; Schuster DM
AJR Am J Roentgenol; 2017 Aug; 209(2):255-269. PubMed ID: 28504563
[TBL] [Abstract][Full Text] [Related]
23. PET imaging to monitor cancer therapy.
Malviya G; Nayak TK
Curr Pharm Biotechnol; 2013; 14(7):669-82. PubMed ID: 24372238
[TBL] [Abstract][Full Text] [Related]
24. The role of 18F-FDG PET in oncology: clinical and resource implications.
Al-Nahhas A; Win Z; Singh A; Khan S; Al-Sayed Y
Nucl Med Rev Cent East Eur; 2006; 9(1):1-5. PubMed ID: 16791796
[No Abstract] [Full Text] [Related]
25. Pitfall of (18)F-FDG-PET imaging in oncology: uterine fibromyoma.
Tripathi M; Khurana A; D'Souza MM; Sharma R
Hell J Nucl Med; 2009; 12(2):175-6. PubMed ID: 19675878
[No Abstract] [Full Text] [Related]
26. The pivotal role of FDG-PET/CT in modern medicine.
Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R; Nadig MR; Chauhan A
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic role of (18)F fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin.
Sioka C; Assimakopoulos A; Fotopoulos A
Eur J Clin Invest; 2015 Jun; 45(6):601-8. PubMed ID: 25823953
[TBL] [Abstract][Full Text] [Related]
29. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
Shiue CY; Welch MJ
Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
[TBL] [Abstract][Full Text] [Related]
30. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
31. Positron Emission Tomography Imaging of Tumor Proliferation and DNA Repair.
Shields AF; Chen DL
Cancer J; 2024 May-Jun 01; 30(3):170-175. PubMed ID: 38753751
[TBL] [Abstract][Full Text] [Related]
32. Molecular imaging of breast cancer.
Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
[TBL] [Abstract][Full Text] [Related]
33. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
34. Could FAP-Targeted Molecular Imaging Replace
Kashyap R; Ravi Kumar AS
J Nucl Med; 2023 Apr; 64(4):623-624. PubMed ID: 36732058
[No Abstract] [Full Text] [Related]
35. [Clinical usefulness of FDG-PET in oncology].
Sasaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
[TBL] [Abstract][Full Text] [Related]
36. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
Comans EF; Hoekstra OS; Hoekman K; van der Hoeven JJ; Golding RP; Teule GJ
Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1520-8. PubMed ID: 10949634
[TBL] [Abstract][Full Text] [Related]
37. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
38. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
[TBL] [Abstract][Full Text] [Related]
39. PET beyond ¹⁸F-FDG: second generation PET tracers in clinical oncology.
Brouwers AH; Glaudemans AW; De Vries EF
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):1-3. PubMed ID: 25854554
[No Abstract] [Full Text] [Related]
40. [Clinical application of 18F-FDG PET/CT in the treatment of sarcomas].
Borbély K; Németh Z; Kásler M
Magy Onkol; 2014 Mar; 58(1):24-31. PubMed ID: 24712003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
